Related Experiment Video
Updated: Aug 8, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Inhibition of viral assembly in murine cells by HIV-1 matrix
Wolfgang Hübner1, Benjamin K Chen
1Department of Pharmacology and Biological Chemistry, Center for Immunobiology, Mount Sinai School of Medicine, One Gustave Levy Place Box 1215, New York, NY 10029, USA.
Abstract:
In human cells, the N-terminal matrix (MA) domain of the human immunodeficiency virus type 1 (HIV-1) Gag targets assembly to specific membrane compartments. In murine fibroblasts, membrane targeting of Gag and assembly of HIV-1 are inefficient. These deficiencies are relieved by replacement of HIV-1 MA with murine leukemia virus (MLV) MA in chimeric proviruses. In this study, we examined chimeric HIV-1 carrying tandem MLV and HIV-1 MA domains and found that the addition of MLV MA to the N-terminus of HIV-1 Gag enhanced membrane binding in murine cells, but was not sufficient to stimulate virus production. Removal of HIV MA was required to observe more efficient Gag processing and increased virus production in murine cells. Deletion of the globular head of MA also alleviated the blocks to membrane binding and Gag processing in murine cells, yet did not lead to increased virus production. These MA-dependent, cell-type-specific phenotypes suggest that host factors interact with the globular head of MA to regulate membrane binding and additional membrane-independent step(s) required for assembly.
Insights
Murine leukemia virus (MLV) matrix (MA) enhances human immunodeficiency virus type 1 (HIV-1) Gag membrane binding in murine cells. However, efficient HIV-1 assembly requires removing HIV-1 MA and involves host factors interacting with MA's globular head.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- The N-terminal matrix (MA) domain of human immunodeficiency virus type 1 (HIV-1) Gag is crucial for targeting viral assembly to specific cellular membrane compartments.
- HIV-1 Gag assembly and membrane targeting are inefficient in murine fibroblasts compared to human cells.
- Chimeric proviruses with murine leukemia virus (MLV) MA can rescue these deficiencies.
Purpose of the Study:
- To investigate the role of MLV MA in enhancing HIV-1 Gag membrane binding and assembly in murine cells.
- To determine the specific domains of MA involved in cell-type-specific assembly phenotypes.
- To elucidate the interaction between MA and host factors in regulating viral assembly.
Main Methods:
- Construction and analysis of chimeric HIV-1 proviruses containing tandem MLV and HIV-1 MA domains.
- Assessment of Gag membrane binding efficiency in murine cells.
- Evaluation of Gag processing and virus production in murine cells.
- Site-directed mutagenesis to delete the globular head of MA.
Main Results:
- Addition of MLV MA to HIV-1 Gag enhanced membrane binding in murine cells but did not fully restore virus production.
- Removal of HIV-1 MA was necessary for efficient Gag processing and increased virus production in murine cells.
- Deletion of the MA globular head partially restored membrane binding and Gag processing but did not enhance virus production.
Conclusions:
- MA-dependent, cell-type-specific phenotypes indicate a complex regulation of HIV-1 assembly.
- Host factors likely interact with the globular head of MA to regulate membrane binding.
- Additional membrane-independent steps are critical for efficient viral assembly, influenced by MA-host factor interactions.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis

